EXACT Sciences Corp.

EXACT Sciences Corp.

EXACT Sciences Corp.

Overview
Date Founded

1995

Headquarters

441 Charmany Drive, Madison, WI, 53719, USA

Type of Company

Public

Employees (Worldwide)

1,977

Industries

Biotechnology
IT Consulting & Services
Medical Support Services

Company Description

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Contact Data
Trying to get in touch with decision makers at EXACT Sciences Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Senior Vice President, General Counsel, Chief Administrative Officer & Secretary

Chief Information Officer

Chief Science Officer

Co-Chief Medical Officer

Co-Chief Medical Officer & Head-Medical Affairs

Benefit Plan Administrator

Senior Vice President, Operations

Senior Vice President, Business Development

Board of Directors

Chairman, President & Chief Executive Officer at EXACT Sciences Corp.

Former Governor of Wisconsin

President at Natural Products Group, Inc.

President at Bioleap, Inc. (Florida)

Former Governor of Kansas

President at Executive Health Resources, Inc.

Chief Investment Officer at Casdin Capital LLC

Chairman, President & Chief Executive Officer at CereVasc LLC

Founder at Perspective Group LLC

Former Chief Executive Officer at Arbonne International LLC

Paths to EXACT Sciences Corp.
Potential Connections via
Relationship Science
You
EXACT Sciences Corp.
Owners & Shareholders
Details Hidden

Winslow Capital specializes in growth investing through its domestic and international equity investments, and alternative investments strategies. The firm's primary investment strategy is their Large-Cap Growth strategy, although they also offer Socially Aware US Large-Cap Growth strategy. Winslow invests primarily in common stocks of US-based companies with market capitalizations typically exceeding $4 billion. The Large-Cap Growth strategy uses a bottom-up fundamentally driven investment approach with an underlying valuation discipline. Portfolios managed according to the International Small Cap strategy invest primarily in equity securities of non-US small-capitalization companies domiciled in the following regions: Europe, Japan, Asia Pacific, and Canada. Winslow Capital's Growth Capital strategy focuses on late stage venture capital investments in privately held companies. Strategy portfolios invest primarily in convertible preferred shares or common shares of private companies according to a fundamentally driven investment approach with an emphasis on valuation relative to public market potential.

Details Hidden

VGI performs fundamental analysis to select investments primarily in equity securities, but also in private equity and other financial instruments. The firm invests in companies around the world that operate in a wide range of industries. They use leverage to magnify the effects of its investment selections. In their fundamental approach to investment selection for the funds, VGI generally performs a number of tasks that may include the following: detailed review of a company's products and services; market analyses to estimate the size of the future market for such products and services; interviews with a company's management team; discussions with a company's current and potential customers and competitors; consultation with industry experts; and where appropriate, a review of the macroeconomic, regulatory and technological dynamics affecting a company's prospects. They may also discuss their investment research and analysis with other industry participants. They also analyzes a company's financial information, paying particular attention to its assets, return on capital, consistency of earnings growth, organic revenue growth and free cash-flow generation.

Details Hidden

Zevenbergen Capital Investments' (ZCI) primary business is providing investment advisory services through individually-managed, aggressive growth equity portfolios.ZCI offers three aggressive growth equity products. The Zevenbergen Growth Equity Portfolio invests in growth companies with varied capitalization ranges. The ZTech Growth Equity Portfolio exhibits sector concentration, investing in growth companies with primary emphasis in the technology, internet and telecommunications industries. The NVM Portfolio solely targets long-term capital appreciation through investment in non-diversified, highly concentrated positions in growth companies.ZCI also advises on fixed-income securities and dividend-yielding equities as part of a client's overall investment objective. The Zevenbergen Income Growth Portfolio is intended to produce income through investments in companies with a history of, and expected future dividend growth.

Recent Transactions
Details Hidden

EXACT Sciences Corp. purchases Genomic Health, Inc.

Details Hidden

EXACT Sciences Corp. purchases Armune BioScience, Inc. from Ann Arbor Spark Business Accelerator, Apjohn Ventures LLC, GA Holding Co. LLC, Biosciences Research & Commercialization Center

Details Hidden

EXACT Sciences Corp. purchases Sampleminded, Inc.

Insider Transactions
Details Hidden
Transaction Advisors
Underwriter

Advised onEXACT Sciences Corp. issued USD Common Stock

Legal Advisor

Advised onEXACT Sciences Corp. issued USD Common Stock

Underwriter

Advised onEXACT Sciences Corp. issued USD Common Stock

Global Joint Head of Pharmaceuticals & Life

Advised onEXACT Sciences Corp. issued USD Common Stock

Managing Director

Advised onEXACT Sciences Corp. issued Common Stock

Legal Advisor

Advised onEXACT Sciences Corp. issued Common Stock

Advisors & Consultants
Advisor

Vice President at Mosinee Telephone Company LLC

Clients

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

At WellPoint, we believe there is an important connection between our members’ health and well-being—and the value we bring our customers and shareholders. So each day we work to improve the health of our members and their communities. WellPoint is one of the nation’s largest health benefits companies, with more than 36 million members in its affiliated health plans and nearly 67 million individuals served through its subsidiaries. One in nine Americans receives coverage for their medical care through WellPoint's affiliated plans. We offer a broad range of medical and specialty products.

Cigna is more than a health insurance company. They are a global health service company. Cigna works with employers and organizations around the world helping employees stay healthy and on the job. They work closely with brokers and consultants to develop innovative programs, help individuals and families improve their health, well-being and sense of security—and lower their medical costs. And, Cigna provides access to a global network of local physicians and hospitals—as well as 24/7/365 live customer service.

Key Stats and Financials As of 2018
Market Capitalization
$11.7B
Total Enterprise Value
$7.28B
Earnings Per Share
$-1.43
Revenue
$454M
Net Profit
$-175M
EBITDA
$-136M
EBITDAMargin
-30.01%
Total Debt
$697M
Total Equity
$681M
Enterprise Value Sales
16.03x
TEVNet Income
-41.59x
Debt TEV
0.1x
Three Year Compounded Annual Growth Rate Of Revenue
125.87%
Five Year Compounded Annual Growth Rate Of Revenue
155.87%
Non-Profit Donations & Grants
$10K - $25K
2014
$10K - $25K
2013
$10K - $15K
2012
Investments
Details Hidden

Thrive Earlier Detection Corp. is a company dedicated to incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph Lengauer and Nickolas Papadopoulos in and is headquartered in Cambridge, MA.

Investors
Details Hidden

Investor at Biomatrica, Inc.

Details Hidden

Senior Vice President of Applications & Product Development at ZS Genetics, Inc.

Details Hidden

Chief Executive Officer at LapidX Research Associates

Suppliers
Hologic, Inc. Medical Support Services | MARLBOROUGH, MA

Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make. Hologic is a market leader in mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of our achievements and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health

Brooks Automation, Inc. Appliances & Electronics | CHELMSFORD, MA

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and breadth of global services provide customers speed to market, high uptime, and rapid response, which equate to superior value in their mission-critical environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market. Through product development initiatives and strategic acquisition, we have expanded our reach to meet the needs of customers in the life sciences industry, analytical and research fields, and clean energy markets. When optimal productivity and high availability are factors for success, customers across the globe turn to Brooks. Brooks is a public company listed on the NASDAQ stock exchange under the symbol BRKS

University of Michigan Other Business & Consulting Services | Ann Arbor, MI

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Competitors
Cambridge Epigenetix Ltd. Other Business & Consulting Services - Cambridge, CA

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Grail, Inc. Biotechnology - MENLO PARK, CA

GRAIL, Inc. develops technology to early detection of cancer. It engages in developing paradigm changing clinical assays for early cancer detection, based on unique biological insights from high intensity sequencing analysis of circulating cell free nucleic acids. The company was founded in 2016 and is headquartered in Menlo Park, CA.

Freenome Holdings, Inc. Medical Products & Equipment - South San Francisco, California

Freenome Holdings, Inc. engages in the development of multiomics platform for early cancer detection. It develops simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. The company was founded by Charles Roberts, Riley Ennis, and Gabriel Otte and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by EXACT Sciences Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of EXACT Sciences Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and EXACT Sciences Corp..